Aclaris Therapeutics (ACRS) Prepaid Assets (2014 - 2025)
Aclaris Therapeutics' (ACRS) quarterly Prepaid Assets came in at $4.2 million in Q2 2025, down 32.41% year-on-year from $6.2 million in Q2 2024, and up 30.25% quarter-over-quarter from $3.2 million in Q1 2025.
Aclaris Therapeutics (ACRS) Prepaid Assets (2014 - 2025) Analysis & Trends
Aclaris Therapeutics' Prepaid Assets history runs 12 years deep, the most recent figure standing at $4.2 million for Q2 2025.
- On a quarterly basis, Prepaid Assets fell 32.41% year-over-year to $4.2 million in Q2 2025; TTM through Jun 2025 was $4.2 million, a 32.41% decrease from a year earlier, with the FY2024 full-year figure at $12.0 million, up 27.37% from the prior year.
- Prepaid Assets improved to $4.2 million in Q2 2025 per ACRS's latest filing, from $3.2 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $19.7 million in Q3 2023 and bottomed at $3.2 million in Q1 2025.
- The 5-year median for Prepaid Assets is $9.0 million (2021), against an average of $9.3 million.
- Across the five-year window, Prepaid Assets jumped 401.74% in 2021 and sank 78.32% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $13.0 million in 2021, then increased by 3.85% to $13.5 million in 2022, then dropped by 29.96% to $9.5 million in 2023, then gained by 27.37% to $12.0 million in 2024, then tumbled by 65.1% to $4.2 million in 2025.
- Per Business Quant, the three latest ACRS Prepaid Assets figures stand at $4.2 million (Q2 2025), $3.2 million (Q1 2025), and $12.0 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aclaris Therapeutics | 705.88 Mn | 705.88 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.20 Mn |
| Mar 31, 2025 | 3.23 Mn |
| Dec 31, 2024 | 12.04 Mn |
| Sep 30, 2024 | 4.27 Mn |
| Jun 30, 2024 | 6.22 Mn |
| Mar 31, 2024 | 6.80 Mn |
| Dec 31, 2023 | 9.45 Mn |
| Sep 30, 2023 | 19.67 Mn |
| Jun 30, 2023 | 12.73 Mn |
| Mar 31, 2023 | 12.87 Mn |
| Dec 31, 2022 | 13.50 Mn |
| Sep 30, 2022 | 7.91 Mn |
| Jun 30, 2022 | 10.11 Mn |
| Mar 31, 2022 | 10.63 Mn |
| Dec 31, 2021 | 13.00 Mn |
| Sep 30, 2021 | 7.09 Mn |
| Jun 30, 2021 | 8.65 Mn |
| Mar 31, 2021 | 5.39 Mn |
| Dec 31, 2020 | 2.59 Mn |
| Sep 30, 2020 | 1.88 Mn |